Navigation Links
ReSearch Pharmaceutical Services anuncia a Marc Wolff como responsable financiero

FORT WASHINGTON, Pennsylvania, 25 de julio de 2013 /PRNewswire/ -- ReSearch Pharmaceutical Services, Inc. (RPS), una CRO de próxima generación que proporciona soluciones de desarrollo clínico global en fase 1-4 para las industrias de dispositivos médicos y biofarmacéutica, anunció hoy que Marc Wolff se une a la organización en el cargo de responsable financiero.

En su cargo, Marc dirigirá todas las finanzas, impuestos y aspectos de tesorería de los negocios, incluyendo las prácticas de contabilidad, presupuesto, planificación financiera, finanzas, interfaz con la comunidad financiera, análisis financiero, adquisiciones y empresas y control del rendimiento financiero, de impuestos y tesorería. Se une a la compañía procedente de Catalent Pharma Solutions, donde trabajó en un doble cargo como responsable de finanzas mundial de Softgel Technologies además de ser vicepresidente y responsable general de Softgel Businesses en Australia y Japón.

Wolff cuenta con más de 15 años de experiencia como responsable financiero en corporaciones públicas y privadas, disponiendo entre 50 millones de dólares y 1.500 millones de dólares en ingresos, con un record establecido de éxito en las principales organizaciones globales de finanzas y un valor empresariales creciente destacado. 

Acerca de RPS
ReSearch Pharmaceutical Services (RPS), el principal proveedor mundial de mercado de innovadoras soluciones de desarrollo clínico de externalización, ofrece soluciones de desarrollo clínico de fase I-IV globales completas para las industrias farmacéutica, biotecnológica, de dispositivos médicos y diagnóstico, personalizadas por tipo (grandes, tamaño medio y pequeño). Construida de forma orgánica, RPS es la organización de investigación clínica (CRO) de crecimiento más rápido dentro de las 10 primeras, y cuenta con más de 5.000 empleados y realiza operaciones en más de 64 países, disponiendo de estructuras internas propias. Estas estructuras han proporcionado a RPS y sus socios una flexibilidad de desarrollo y crecimiento superior.

Si desea más información sobre RPS, visite

SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Water Treatment Industry Reports: Equipment Research for US & Global Wastewater Treatment Markets
2. Organovo and Methuselah Foundation Announce Funding of Bioprinting Research at Research Institutions
3. Exosome Diagnostics and QIAGEN Partner to Launch Comprehensive Line of Biofluid Nucleic Acid Kits to Address Limitations of Tissue Biopsy in Clinical Research Market
4. BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. as Vice President of Clinical Research & Regulatory Affairs
5. Pain Management Devices Market (Electrical Stimulators, Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) Is Expected to Reach USD 5.0 Billion Globally in 2018: Transparency Market Research
6. Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growt
7. ResearchDx, the leading Contract Diagnostics Organization, completes their expansion into a new facility
8. Heptares Achieves First Research Milestone in Research Collaboration with Cubist
9. Leadership Through Research Collaboration Is Reflected In Articles Published In Alzheimers Association Journal
10. Todays Research: Delcath Systems, Astex Pharma, BioMarin Pharma, and Akorn
11. Froedtert & The Medical College of Wisconsin Clinical Cancer Center Joins Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy
Post Your Comments:
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
Breaking Medicine News(10 mins):